Pharmalogic Holdings Corp.

Boca Raton, FL Doing business as Pharmalogic Puerto Rico

UEI
HVFXH4DBMXF2
CAGE
7GAD2
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
5301 N Federal Hwy #280, Boca Raton, FL 33487, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Pharmalogic Holdings Corp.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Radiopharmaceuticals for pet imaging Contract · 36C25926P0374 Veterans Integrated Service Network 19 $541,308
Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose Contract · 36C24926N0267 Veterans Integrated Service Network 9 $628,875
Radiopharmaceuticals Contract · 36C26326N0165 Veterans Integrated Service Network 23 $200,256
Pylarify 18 5 year ordering period Contract · 36C24926N0007 Veterans Integrated Service Network 9 $577,395
Radiopharmacutial 1 F18-florbetapir neuraceq per unit dose Contract · 36C24926N0137 Veterans Integrated Service Network 9 $279,500

About Pharmalogic Holdings Corp.

Written by GovTribe AI ·

Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, supplies radiopharmaceuticals for positron emission tomography and nuclear medicine diagnostic imaging to the Department of Veterans Affairs as a prime contractor operating entirely in the full-and-open competitive space with no set-aside designations (with one exception noted below). The company is a for-profit corporation headquartered in Boca Raton, Florida, classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing), with a portfolio that spans 15 subsidiaries including Clinical Pharmacy Services Inc., Blue Ridge Isotopes LLC, Nuclear Diagnostic Products Inc., and regional radiopharmacy operations in Syracuse, Paducah, Philadelphia, and Maine.

All 21 awards in the source data are prime contracts or indefinite delivery vehicles; Pharmalogic holds no sub positions. The customer base is entirely concentrated within the Department of Veterans Affairs, split across five Veterans Integrated Service Networks. VISN 9 (Lexington, Kentucky) leads by potential value with 8 awards totaling $8.8 million, anchored by a $2.62 million total small business set-aside indefinite delivery contract (awarded October 1, 2024, through September 30, 2029) for PYLARIFY F-18 piflufolastat prostate cancer imaging radiopharmaceuticals, and a $978 thousand total small business set-aside Blanket Purchase Agreement (awarded March 15, 2025, through March 14, 2030) for F18-florbetapir (NeuraCeq) neurological diagnostic doses. VISN 23 (Highland Beach, Florida) follows with 10 awards worth $5 million combined potential value, including a $1.2 million single-award indefinite delivery contract awarded October 1, 2025, for multi-use radiopharmaceuticals (F-18 FDG, PYLARIFY, and F18-florbetapir). VISN 19 holds one $2.2 million purchase order (awarded April 8, 2026) for radiopharmaceuticals including F-18 piflufolastat and quality assurance sources through April 7, 2030. Representative recent work includes a $628 thousand BPA call from VISN 9 (March 15, 2026) for F18-florbetapir doses through March 14, 2030, and a $491 thousand purchase order from VISN 12 (May 1, 2025) for 18F-FDG doses as-needed through April 30, 2026.

Activity accelerated sharply in 2025 (nine awards) and early 2026 (two awards, including the largest single award) compared to prior years (two in 2022, one in 2023, four in 2024). The combined potential value across all awards is $17.1 million, with $4.6 million obligated to date (27% drawn). Only one award—a $200 thousand delivery order—carries an ultimate completion date within the next twenty-four months, presenting minimal recompete cliff risk in the near term; the larger vehicles run through 2029 and 2030. Pharmalogic's footprint consists entirely of drug and biologicals supply (PSC code, 17 awards) and medical imaging equipment and supplies (4 awards) to support VA nuclear medicine programs. Performance locations include Lexington, Kentucky; Highland Beach, Florida; and Boca Raton, Florida, reflecting the distributed nature of radiopharmaceutical manufacturing and distribution across the subsidiary network.

Quick answers

What is Pharmalogic Holdings Corp.'s UEI?

Pharmalogic Holdings Corp.'s Unique Entity ID (UEI) in SAM.gov is HVFXH4DBMXF2.

What is Pharmalogic Holdings Corp.'s CAGE code?

Pharmalogic Holdings Corp.'s CAGE code is 7GAD2.

What is Pharmalogic Holdings Corp.'s primary NAICS code?

Pharmalogic Holdings Corp.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Pharmalogic Holdings Corp. located?

Pharmalogic Holdings Corp.'s physical address in SAM.gov is 5301 N Federal Hwy #280, Boca Raton, FL 33487, USA.

Is Pharmalogic Holdings Corp. registered in SAM.gov?

Yes. Pharmalogic Holdings Corp.'s SAM.gov registration is active through December 22, 2026.

What is Pharmalogic Holdings Corp.'s most recent federal award?

Pharmalogic Holdings Corp.'s most recent federal contract award is Radiopharmaceuticals for pet imaging (36C25926P0374), from Veterans Integrated Service Network 19, on April 8, 2026.

On GovTribe

See Pharmalogic Holdings Corp.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login